Caraco recalls all digoxin tablets due to size variability
This article was originally published in Scrip
Executive Summary
Caraco Pharmaceutical Laboratories, the US subsidiary of India's Sun Pharmaceutical Industries, has notified US healthcare professionals of a voluntary, consumer-level recall of all digoxin 0.125mg and 0.25mg tablets manufactured by the firm and distributed before March 31st, 2009, which are within the expiry date of September 2011.